Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Bias in emerging biomarkers for bipolar disorder

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Cognitive functioning following discontinuation of antipsychotic medication. A naturalistic sub-group analysis from the OPUS II trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Assessing risk of neurodevelopmental disorders after birth with oxytocin: a systematic review and meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Associations between P3a and P3b amplitudes and cognition in antipsychotic-naïve first-episode schizophrenia patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Startle habituation, sensory, and sensorimotor gating in trauma-affected refugees with posttraumatic stress disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Group rumination-focused cognitive-behavioural therapy (CBT) v. group CBT for depression: phase II trial

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: To date no comprehensive evaluation has appraised the likelihood of bias or the strength of the evidence of peripheral biomarkers for bipolar disorder (BD). Here we performed an umbrella review of meta-analyses of peripheral non-genetic biomarkers for BD.

METHOD: The Pubmed/Medline, EMBASE and PsycInfo electronic databases were searched up to May 2015. Two independent authors conducted searches, examined references for eligibility, and extracted data. Meta-analyses in any language examining peripheral non-genetic biomarkers in participants with BD (across different mood states) compared to unaffected controls were included.

RESULTS: Six references, which examined 13 biomarkers across 20 meta-analyses (5474 BD cases and 4823 healthy controls) met inclusion criteria. Evidence for excess of significance bias (i.e. bias favoring publication of 'positive' nominally significant results) was observed in 11 meta-analyses. Heterogeneity was high for (I 2 ⩾ 50%) 16 meta-analyses. Only two biomarkers met criteria for suggestive evidence namely the soluble IL-2 receptor and morning cortisol. The median power of included studies, using the effect size of the largest dataset as the plausible true effect size of each meta-analysis, was 15.3%.

CONCLUSIONS: Our findings suggest that there is an excess of statistically significant results in the literature of peripheral biomarkers for BD. Selective publication of 'positive' results and selective reporting of outcomes are possible mechanisms.

Original languageEnglish
JournalPsychological Medicine
Volume46
Issue number11
Pages (from-to)2287-2297
Number of pages11
ISSN0033-2917
DOIs
Publication statusPublished - 1 Aug 2016

ID: 46481423